Alivernini, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 2.873
EU - Europa 2.491
AS - Asia 1.212
SA - Sud America 184
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 6.794
Nazione #
US - Stati Uniti d'America 2.837
IT - Italia 533
SG - Singapore 473
SE - Svezia 427
CN - Cina 417
PL - Polonia 376
DE - Germania 317
FR - Francia 224
BR - Brasile 162
IE - Irlanda 160
UA - Ucraina 95
ID - Indonesia 91
GB - Regno Unito 84
IN - India 76
FI - Finlandia 68
RU - Federazione Russa 46
HK - Hong Kong 34
TR - Turchia 32
BE - Belgio 30
NL - Olanda 25
AT - Austria 23
CA - Canada 23
JP - Giappone 17
CI - Costa d'Avorio 13
IR - Iran 13
VN - Vietnam 13
MX - Messico 12
ES - Italia 10
CH - Svizzera 9
IL - Israele 8
LT - Lituania 8
GR - Grecia 7
RO - Romania 7
AR - Argentina 6
BD - Bangladesh 6
CZ - Repubblica Ceca 6
CL - Cile 5
EE - Estonia 5
LV - Lettonia 5
MD - Moldavia 5
ZA - Sudafrica 5
MA - Marocco 4
MY - Malesia 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
AU - Australia 3
DK - Danimarca 3
EC - Ecuador 3
HU - Ungheria 3
IQ - Iraq 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
TW - Taiwan 3
UY - Uruguay 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
CO - Colombia 2
EU - Europa 2
KR - Corea 2
LK - Sri Lanka 2
LU - Lussemburgo 2
NG - Nigeria 2
PH - Filippine 2
PK - Pakistan 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
JM - Giamaica 1
KE - Kenya 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 6.794
Città #
Chandler 508
Warsaw 365
Singapore 282
Ashburn 261
Fairfield 168
Dublin 143
Rome 140
Wilmington 115
New York 108
Dearborn 104
Woodbridge 98
Ann Arbor 96
Seattle 91
Jakarta 90
Houston 75
Nanjing 72
Milan 70
Cambridge 68
Cattolica 62
The Dalles 59
Jacksonville 54
San Mateo 53
Beijing 50
Princeton 50
Boston 48
Chicago 46
Bremen 44
Marseille 35
Helsinki 33
Hong Kong 31
Moscow 29
Redwood City 28
Los Angeles 26
North Bergen 26
Brussels 24
Izmir 24
Pune 23
Redmond 22
Munich 21
London 20
Boardman 19
Frankfurt am Main 19
Lawrence 19
Nanchang 19
Nuremberg 19
Kunming 16
Tianjin 16
Norwalk 15
Shenyang 15
Guangzhou 14
Hangzhou 14
Abidjan 13
Lancaster 13
Toronto 13
Andover 11
Lappeenranta 11
Dong Ket 10
Hebei 10
Mountain View 10
Santa Maria 10
São Paulo 10
Tokyo 10
Vienna 10
Washington 10
Busto Arsizio 9
San Diego 9
Falkenstein 8
Fuzhou 8
Lauterbourg 8
Paris 8
Augusta 7
Jiaxing 7
Jinan 7
Leawood 7
Newark 7
Nürnberg 7
Strasbourg 7
Zurich 7
Brasília 6
Des Moines 6
Dijon 6
Düsseldorf 6
Falls Church 6
Parma 6
Phoenix 6
Portsmouth 6
San Vito Chietino 6
Amsterdam 5
Boydton 5
Brno 5
Catania 5
Council Bluffs 5
Herenthout 5
Kraków 5
Shanghai 5
University Park 5
Vancouver 5
Zhengzhou 5
Athens 4
Changsha 4
Totale 4.211
Nome #
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 303
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 285
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 276
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 214
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 202
Synovial tissue macrophages: friend or foe? 152
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 150
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 148
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 145
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 130
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 117
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 112
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 109
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 106
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 105
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 105
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 102
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 100
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 98
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 96
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 96
Postural control and disability in patients with early rheumatoid arthritis 94
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 92
Sarilumab use in severe SARS-CoV-2 pneumonia 92
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 90
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 89
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 86
Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission 82
The pathogenesis of rheumatoid arthritis 81
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 81
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 81
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 78
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 78
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 78
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 75
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 71
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 71
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 68
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 68
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 68
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 68
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 68
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 67
Malnutrition in COVID-19 survivors: prevalence and risk factors 64
Malnutrition in COVID-19 survivors: prevalence and risk factors 63
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 63
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 62
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 62
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 62
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 60
Ultrasound assessment as predictor of disease relapse in children and adults with arthritis in clinical stable remission: new findings but still unmet needs 59
The B side of rheumatoid arthritis pathogenesis 58
Biomarkers of joint damage in rheumatoid arthritis: where are we in 2013? 57
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 57
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 56
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 56
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 55
Telemedicine will not keep us apart in COVID-19 pandemic 54
COVID-19 atypical Parsonage-Turner syndrome: a case report 53
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 53
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study 52
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 52
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 50
RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection 50
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 45
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 45
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 43
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 43
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 42
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 41
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 41
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 40
Bispecific T cell engager therapy for refractory rheumatoid arthritis 37
Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48 36
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 35
Using explainable artificial intelligence to predict and forestall flare in rheumatoid arthritis 34
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 34
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 33
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution 31
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations 31
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 31
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 30
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 28
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis 25
Driving chronicity in rheumatoid arthritis: Perpetuating role of myeloid cells 24
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 19
Evaluating antirheumatic treatments using synovial biopsy: A recommendation for standardisation to be used in clinical trials 19
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 18
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 13
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 13
Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis 13
Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing 11
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages 7
Exploring perinatal mesenchymal stromal cells as a potential therapeutic strategy for rheumatoid arthritis 2
Totale 6.939
Categoria #
all - tutte 36.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020119 0 0 0 0 0 0 0 0 0 0 80 39
2020/2021568 59 43 26 34 75 38 49 11 73 63 72 25
2021/2022719 95 46 32 52 45 18 15 74 44 51 97 150
2022/20231.525 177 184 114 231 115 187 65 121 191 62 51 27
2023/20241.056 42 219 50 52 43 189 96 37 39 70 141 78
2024/20251.342 36 38 152 97 149 83 90 88 303 230 76 0
Totale 6.939